seizure prediction, epilepsy, deep learning AI, future-guided AI, EEG monitoring, personalized medicine, neurology, predictive analytics, patient safety, wearable EEG, real-time seizure forecast, clinical AI, hospital neurology, epilepsy research, AI in healthcare
Innovative AI Boosts Epilepsy Seizure Prediction by 44%

Transforming Seizure Prediction in Epilepsy Seizure prediction remains a critical challenge in epilepsy management, with.

Respiratory Failure, Acute Respiratory Failure, Hypnosis in Medicine, Non-Invasive Ventilation, Emergency Medicine Research, Respiratory Care, NIV Tolerance, Patient Comfort, Critical Care, COPD Treatment, Sedation Alternatives
Hypnosis Boosts NIV Tolerance in Respiratory Failure

A New Approach: Hypnosis Improves NIV Tolerance in Acute Respiratory Failure Patients Acute respiratory failure.

microneedle patch, bee-sting inspired patch, pain-free drug delivery, neurological diseases, Alzheimer’s treatment, Parkinson’s disease therapy, EW-MNs, continuous drug delivery, electrospun microneedles, self-administered medication, patient-friendly drug delivery, chronic disease management, painless treatment patch, healthcare innovation, needle-free drug delivery
Bee-Sting Microneedle Patch for Painless Drug Delivery

Microneedle Patch: A Pain-Free Alternative for Long-Term Treatment Millions of patients with neurological and chronic.

Atrial Fibrillation, Anticoagulation, Stroke Prevention, Artificial Intelligence in Cardiology, AF Clinical Decision-Making, Mount Sinai Research, Precision Medicine, Patient-Specific Treatment, Blood Thinners, Cardiac Arrhythmia Management, AI in Healthcare, Bleeding Risk Assessment, Stroke Risk Prediction, Clinical Trials in AF, Shared Decision-Making
AI Reshapes Anticoagulation in Atrial Fibrillation Care

Understanding the Challenge of Atrial Fibrillation Treatment Atrial Fibrillation (AF) is the most common cardiac.

Hemoglobin as Brain Antioxidant in Neurodegenerative Disease

Uncovering the Brain’s Own Defense Against Oxidative Stress Hemoglobin, long recognized for its role in.

Progressive MS research, MS Clinical and Imaging Data Resource, multiple sclerosis clinical trials, neuroimaging biomarkers, AI in MS, MRI scans MS, progressive MS treatment, MS Alliance, harmonized MS data, neurologists MS research, machine learning MS, MS progression biomarkers, global MS collaboration, MS patient recovery, clinical trial efficiency
Global Data Resource for Progressive MS Research (Multiple Sclerosis)

The International Progressive MS Alliance has launched the MS Clinical and Imaging Data Resource (CIDR),.

AI diabetes risk detection, continuous glucose monitoring, PROGRESS study, personalized glycemic risk profiles, type 2 diabetes prediction, prediabetes risk assessment, postprandial glucose spikes, machine learning diabetes model, gut microbiome and glucose control, HbA1c limitations, multimodal glycemic profiling, early diabetes intervention strategies, nocturnal hypoglycemia metrics, physical activity and glucose regulation, CGM in clinical practice
AI Diabetes Risk Detection: Early T2D Prediction

A new frontier in early diabetes intervention A groundbreaking study published in Nature Medicine highlights.

Cancer, Immunotherapy, Oncology news, Medical innovation, Drug complex, Tumor targeting, Healthcare professionals, T cell response, Clinical research, Oncology breakthroughs, Cancer detection, Biologic drugs, Medical news for nurses, Precision cancer care, Immune checkpoint therapy, cancer cells
Cancer Cells Learn to Self-Report: A New Frontier in Immunotherapy

How a Drug Complex Enables Immune Detection of Tumors In a major leap for cancer.

Staphylococcus aureus, MRSA, Metabolic Pathways, Enzyme Redundancy, Bacterial Survival, Antibiotic Resistance, Microbial Physiology, Knockout Mutants, NIH Research, Pathogen Biology, Novel Antibiotics, Microbiology CME, Infectious Disease Updates, Antibiotic Target Discovery, Clinical Research News
Staphylococcus Shows Complex Enzyme Redundancy, Study Finds

A Bacterial Pathogen That Refuses to Fail In a recent study published in mBio, researchers.

Parkinson's disease, weekly injectable drug, levodopa, carbidopa, long-acting injectable, PLGA, Eudragit L-100, UniSA, biodegradable formulation, patient adherence, neurological disorder, chronic conditions, in-situ implant, FDA-approved polymer, treatment outcomes
Parkinson’s Disease Care Advances with Weekly Injectable

A new weekly injectable formulation of levodopa and carbidopa, developed by the University of South.